3007

COM:PHARMARON

Pharmaron

  • Stock

Last Close

28.38

22/11 07:04

Market Cap

31.15B

Beta: -

Volume Today

28.97M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
21.00M
-
73.85M
251.73%
176.91M
139.57%
227.02M
28.33%
339.03M
49.33%
530.67M
56.53%
1.15B
116.14%
1.62B
41.25%
1.35B
16.54%
1.60B
18.41%
depreciation and amortization
51.26M
-
63.69M
24.25%
92.88M
45.84%
144.63M
55.72%
211.69M
46.37%
317.67M
50.06%
375.16M
18.10%
497.92M
32.72%
696.18M
39.82%
1.01B
44.87%
deferred income tax
5.26M
-
-11.52M
-
28.44M
346.83%
-67.53M
337.41%
-177.17M
162.37%
-63.63M
64.09%
stock based compensation
8.19M
-
11.52M
-
62.46M
442.00%
67.53M
8.12%
177.17M
162.37%
-1.95B
1,202.59%
change in working capital
-109.22M
-
1.36M
101.24%
-106.76M
7,956.29%
66.69M
162.47%
43.07M
35.42%
-61.12M
241.90%
234.59M
483.81%
130.04M
44.57%
-346.47M
366.43%
63.67M
118.38%
accounts receivables
-286.41M
-
-95.35M
66.71%
-216.31M
126.86%
-786.73M
263.71%
-480.10M
38.97%
inventory
-13.37M
-
-18.44M
37.96%
-45.55M
146.98%
-1.36M
97.01%
-28.29M
1,976.57%
-37.96M
34.17%
-120.05M
216.28%
-224.88M
87.32%
-120.89M
46.24%
82.43M
168.19%
accounts payables
8.07M
-
421.54M
5,123.51%
114.70M
72.79%
78.80M
31.30%
461.34M
485.43%
other working capital
-95.85M
-
19.80M
120.66%
-61.21M
409.11%
68.05M
211.18%
71.36M
4.86%
255.18M
257.59%
28.44M
88.85%
456.52M
1,504.99%
482.35M
5.66%
-1
100.00%
other non cash items
35.65M
-
78.04M
118.89%
72.74M
6.80%
113.86M
56.55%
143.47M
26.00%
151.37M
5.51%
-199.03M
231.49%
-189.99M
4.54%
440.96M
332.10%
2.15B
386.84%
net cash provided by operating activities
12.13M
-
216.94M
1,687.77%
235.77M
8.68%
552.22M
134.22%
737.26M
33.51%
938.59M
27.31%
1.65B
75.65%
2.06B
24.84%
2.14B
4.12%
2.80B
30.81%
investments in property plant and equipment
-81.94M
-
-258.32M
215.26%
-1.06B
308.59%
-934.67M
11.45%
-640.99M
31.42%
-754.61M
17.73%
-1.32B
74.37%
-2.09B
59.05%
-2.95B
40.95%
-2.87B
2.87%
acquisitions net
-222.64M
-
-80.73M
63.74%
-345.60M
328.10%
-59.50M
-
-791.52M
1,230.35%
-1.23B
55.46%
-1.02B
16.96%
961.37M
194.08%
purchases of investments
-3.27M
-
-96.00M
-
-693.94M
622.88%
-2.64B
279.82%
-4.93B
86.98%
-2.34B
52.60%
-2.11B
9.51%
sales maturities of investments
1.06B
-
491.34M
-
1.39B
183.02%
2.99B
114.87%
4.10B
37.09%
2.67B
34.80%
other investing activites
5.31K
-
73.11K
1,276.84%
-1.06B
1,443,792.44%
359.44K
100.03%
22.38M
6,126.96%
-28.50M
227.34%
-18.55M
34.92%
5.49M
129.60%
3.15M
42.53%
net cash used for investing activites
-81.93M
-
-480.89M
486.92%
-1.14B
136.87%
-1.28B
12.36%
-714.60M
44.17%
-1.05B
46.26%
-3.37B
222.53%
-5.26B
55.98%
-2.21B
58.00%
-1.35B
39.01%
debt repayment
-108.58M
-
-138.22M
27.30%
-147.48M
6.70%
-219.82M
49.06%
-423.68M
92.74%
-1.29B
204.31%
-760.96M
40.98%
-158.55M
79.16%
-612.58M
286.35%
-3.61B
489.60%
common stock issued
5.05B
-
-13.15M
100.26%
-295.55M
2,147.75%
7.29M
102.47%
-207.95M
2,950.92%
common stock repurchased
-5.05B
-
13.15M
100.26%
-284.06M
2,260.38%
-393.38M
38.49%
-830.02K
99.79%
dividends paid
-14.90M
-
-15.92M
6.87%
-14.41M
9.47%
-60.60M
320.43%
-74.60M
23.10%
-143.19M
91.96%
-135.40M
5.44%
-284.72M
110.27%
-404.76M
42.16%
-357.35M
11.71%
other financing activites
165.58M
-
452.27M
173.14%
1.44B
219.03%
852.66M
40.90%
482.72M
43.39%
5.68B
1,076.34%
616.19M
89.15%
4.68B
660.20%
-13.83M
100.30%
7.14B
51,711.40%
net cash used provided by financing activities
42.10M
-
298.13M
608.10%
1.28B
329.66%
572.23M
55.33%
-15.56M
102.72%
4.25B
27,390.36%
-280.18M
106.60%
3.66B
1,406.81%
-1.42B
138.71%
2.96B
308.99%
effect of forex changes on cash
900.11K
-
2.58M
186.26%
9.30M
261.07%
-12.88M
238.45%
6.53M
150.73%
-4.28M
165.49%
-85.67M
1,902.02%
-45.52M
46.87%
72.99M
260.37%
11.43M
84.34%
net change in cash
-26.80M
-
36.76M
237.18%
386.96M
952.68%
-168.34M
143.50%
13.63M
108.10%
4.13B
30,228.01%
-2.09B
150.50%
415.78M
119.91%
-1.41B
439.12%
4.42B
413.58%
cash at beginning of period
65.02M
-
38.23M
41.21%
74.99M
96.16%
461.94M
516.03%
293.60M
36.44%
307.24M
4.64%
4.44B
1,345.87%
2.35B
47.01%
2.77B
17.66%
1.50B
45.93%
cash at end of period
38.23M
-
74.99M
96.16%
461.94M
516.03%
293.60M
36.44%
307.24M
4.64%
4.44B
1,345.87%
2.35B
47.01%
2.77B
17.66%
1.36B
50.91%
5.92B
335.31%
operating cash flow
12.13M
-
216.94M
1,687.77%
235.77M
8.68%
552.22M
134.22%
737.26M
33.51%
938.59M
27.31%
1.65B
75.65%
2.06B
24.84%
2.14B
4.12%
2.80B
30.81%
capital expenditure
-81.94M
-
-258.32M
215.26%
-1.06B
308.59%
-934.67M
11.45%
-640.99M
31.42%
-754.61M
17.73%
-1.32B
74.37%
-2.09B
59.05%
-2.95B
40.95%
-2.87B
2.87%
free cash flow
-69.80M
-
-41.38M
40.71%
-819.72M
1,880.78%
-382.45M
53.34%
96.27M
125.17%
183.98M
91.10%
332.77M
80.87%
-34.78M
110.45%
-807.04M
2,220.58%
-62.30M
92.28%

All numbers in (except ratios and percentages)